메뉴 건너뛰기




Volumn 15, Issue 3, 1996, Pages 259-261

Nosocomial Bacteremia due to Vancomycin-Resistant Staphylococcus epidermidis in Four Patients with Cancer, Neutropenia, and Previous Treatment with Vancomycin

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; COTRIMOXAZOLE; IMIPENEM; OFLOXACIN; QUINOLONE DERIVATIVE; TEICOPLANIN; VANCOMYCIN;

EID: 0029939127     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01591369     Document Type: Article
Times cited : (28)

References (5)
  • 1
    • 0025236663 scopus 로고    scopus 로고
    • Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever
    • Hughes WT, Armstrong D, Bodey G, and the IDSA Working Group 1990: Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Journal of Infectious Diseases, 161: 381-396.
    • Journal of Infectious Diseases , vol.161 , pp. 381-396
    • Hughes, W.T.1    Armstrong, D.2    Bodey, G.3
  • 2
    • 0027289342 scopus 로고
    • Management of fever in patients with cancer and treatment-induced neutropenia
    • Pizzo P: Management of fever in patients with cancer and treatment-induced neutropenia. New England Journal of Medicine 1993, 328: 1323-1332.
    • (1993) New England Journal of Medicine , vol.328 , pp. 1323-1332
    • Pizzo, P.1
  • 3
    • 0026728509 scopus 로고
    • Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime
    • Ramphal R, Bolger M, Oblohn DJ: Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime. Antimicrobial Agents and Chemotherapy 1992, 36: 1062-1067.
    • (1992) Antimicrobial Agents and Chemotherapy , vol.36 , pp. 1062-1067
    • Ramphal, R.1    Bolger, M.2    Oblohn, D.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.